Annual zoledronic acid infusion lowers risk of fracture, death

MOspace/Manakin Repository

Breadcrumbs Navigation

Annual zoledronic acid infusion lowers risk of fracture, death

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/5403

[+] show full item record


Title: Annual zoledronic acid infusion lowers risk of fracture, death
Author: Schumann, Sarah-Anne; Hickner, John
Keywords: hip fracture
bisphosphonate
zoledronic acid
Date: 2007-12
Publisher: Family Physicians Inquiries Network
Citation: Journal of Family Practice, 56(12) 2007: 1013-1016.
Abstract: Patients with a prior hip fracture have 2.5 times the risk of a new fracture compared to age-matched persons without a previous hip fracture. For patients with a recent hip fracture, intravenous zoledronic acid annually is an option for reducing the risk of new fractures and death. Strength of recommendation (SOR) B: based on one well- designed randomized controlled trial.
URI: http://hdl.handle.net/10355/5403

This item appears in the following Collection(s)

[+] show full item record